Overview Comparing Efficacy and Safety of CTO0303 in Pediatric Subjects Status: RECRUITING Trial end date: 2025-03-01 Target enrollment: Participant gender: Summary This is a prospective randomized study compared with active control arm.Phase: PHASE2 Details Lead Sponsor: Taejoon Pharmaceutical Co., Ltd.